Detalhe da pesquisa
1.
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies.
Blood
; 137(3): 323-335, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32967009
2.
Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure.
Blood
; 135(19): 1650-1660, 2020 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32076701
3.
Versican Deficiency Significantly Reduces Lung Inflammatory Response Induced by Polyinosine-Polycytidylic Acid Stimulation.
J Biol Chem
; 292(1): 51-63, 2017 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27895126
4.
Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 24(2): 242-251, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29024803
5.
Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering.
J Immunother Cancer
; 11(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36918221
6.
Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy.
Nat Commun
; 11(1): 219, 2020 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31924795
7.
Coevolutionary cycling of host sociality and pathogen virulence in contact networks.
J Theor Biol
; 261(4): 561-9, 2009 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-19712687
8.
Subepithelial Accumulation of Versican in a Cockroach Antigen-Induced Murine Model of Allergic Asthma.
J Histochem Cytochem
; 64(6): 364-80, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27126823